Obinutuzumab Treatment of Follicular Lymphoma
N Engl J Med
.
2017 Dec 28;377(26):2605-2606.
doi: 10.1056/NEJMc1714337#SA2.
Authors
Robert Marcus
1
,
John F Seymour
2
,
Wolfgang Hiddemann
3
Affiliations
1
King’s College Hospital, London, United Kingdom marcus.re@googlemail.com
2
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
3
Ludwig-Maximilians-University Hospital, Munich, Germany
PMID:
29281572
DOI:
10.1056/NEJMc1714337#SA2
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized*
Humans
Lymphoma, Follicular*
Rituximab
Substances
Antibodies, Monoclonal, Humanized
Rituximab
obinutuzumab